This inventor holds 2 USPTO granted patents. Top assignee: Massachusetts Institute of Technology. Active years: 2016-2023.
Location History:
- Cambridge, MA (US) (2016)
- North Chicago, IL (US) (2023)
Company Filing History:
Years Active: 2016-2023
Title: Innovations of Steven A Castleberry
Introduction
Steven A Castleberry is an accomplished inventor based in Cambridge, MA (US). He has made significant contributions to the field of polymer-drug conjugates and nucleic acid delivery systems. With a total of 2 patents, his work focuses on advancing medical treatments through innovative technologies.
Latest Patents
Castleberry's latest patents include a "Nano-fibular nanoparticle polymer-drug conjugate for sustained dermal delivery of retinoids." This invention discloses conjugated polymers that comprise a polymer and an all-trans retinoic acid (ATRA) prodrug covalently bound to the polymer by a hydrolysable linker. The method aims to treat certain disorders effectively. Another notable patent is for "Compositions and methods for nucleic acid delivery." This invention provides multilayer film coating compositions and methods for delivering nucleic acid agents with a controlled release profile, enhancing their biological effectiveness.
Career Highlights
Castleberry is affiliated with the Massachusetts Institute of Technology, where he continues to push the boundaries of research and innovation. His work has garnered attention for its potential applications in medical treatments and drug delivery systems.
Collaborations
He has collaborated with notable colleagues, including Paula T Hammond and Mohiuddin A Quadir, contributing to a dynamic research environment that fosters innovation.
Conclusion
Steven A Castleberry's contributions to the field of polymer-drug conjugates and nucleic acid delivery systems highlight his role as a leading inventor. His innovative patents reflect a commitment to advancing medical science and improving patient outcomes.